
Health
After Ebola, a Blueprint Emerges to Jump-Start R&D
Accelerated testing of compounds that have shown efficacy against the virus may lead to new drugs and vaccines
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account